Pemtero

Pemtero

pemetrexed

Manufacturer:

Amarox
Concise Prescribing Info
Contents
Pemetrexed
Indications/Uses
In combination w/ cisplatin for chemotherapy-naive patients w/ unresectable malignant pleural mesothelioma. 1st-line treatment w/ cisplatin in patients w/ locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. Monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease have not progressed immediately following platinum-based chemotherapy. As a single-agent for the treatment of patients w/ locally advanced or metastatic nonsquamous non-small cell lung cancer after prior chemotherapy (as 2nd line).
Dosage/Direction for Use
As directed by physician.
Special Precautions
Not for the treatment of patients w/ squamous cell non-small cell lung cancer.
ATC Classification
L01BA04 - pemetrexed ; Belongs to the class of antimetabolites, folic acid analogues. Used in the treatment of cancer.
Presentation/Packing
Form
Pemtero lyo powd for inj 100 mg
Packing/Price
1's
Form
Pemtero lyo powd for inj 500 mg
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in